Volume 21, Number 8—August 2015
Macrolide-Resistant Mycoplasma pneumoniae, United States1
|No. tested||No. (%) macrolide resistant|
|Chicago, IL||23||4 (17.4)|
|Kansas City, MO||40||3 (7.5)|
|Hackensack, NJ||2||1 (50.0)|
|New York, NY||5||2 (40.0)|
|Seattle, WA||15||1 (6.7)|
|Birmingham, AL||6||1 (16.7)|
1Preliminary results from this study were presented at the 114th General Meeting of the American Society for Microbiology, Boston, Massachusetts, USA, May 17–20, 2014.
Page created: July 15, 2015
Page updated: July 15, 2015
Page reviewed: July 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.